What's Going On With Ventyx Biosciences On Monday? - Ventyx Biosciences (NASDAQ:VTYX)

Ventyx Biosciences provides clinical and pipeline updates, revealing compelling results in NLRP3 inhibitor development. CEO Raju Mohan announces pipeline reprioritization and strategic financing for continued advancement.

Related Keywords

,Ventyx Biosciences ,Ventyx Biosciences Inc ,Raju Mohan ,Key Symptom Score ,